v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2020-001527-14-NL |
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001527-14/NL |
First author
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
j.aerts@erasmusmc.nl |
Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
2020-04-06 |
Recruitment status
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Recruiting |
Study design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Randomized |
Design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Open label |
Center
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Proven diagnosis of COVID-19 by positive PCR in any specimen < 48 hours prior to randomization. Age ≥ 18 year Hospitalized patients with illness of any duration, and SpO2 ≤ 94% on room air Proven diagnosis of COVID-19 by positive PCR in any specimen < 48 hours prior to randomization. Age ≥ 18 year Hospitalized patients with illness of any duration, and SpO2 ≤ 94% on room air |
Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Severe hypoxemic respiratory failure expected to die < 72 hours after admission ICU admission < 72 hours Allergy for chloroquine or azithromycin Pregnancy QT-prolongation: pre-existent: QTc males >450ms, QTc females > 470ms at day 1 and at day 2 Myasthenia gravis Epilepsy Severe hypoxemic respiratory failure expected to die < 72 hours after admission ICU admission < 72 hours Allergy for chloroquine or azithromycin Pregnancy QT-prolongation: pre-existent: QTc males >450ms, QTc females > 470ms at day 1 and at day 2 Myasthenia gravis Epilepsy |
Number of arms
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
2 |
Funding
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Erasmus MC |
Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
None |
Countries
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Netherlands |
Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
60 |
primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
The initial response to treatment will be evaluated during admission. Cure is considered when 3 criteria are present: (1) O2 sat > 94% with room air (2) 24 hours without fever (≥38°C) (3) Breathing frequency < 24/min The percentage of patients with clinical cure at day 7 will be calculated The initial response to treatment will be evaluated during admission. Cure is considered when 3 criteria are present: (1) O2 sat > 94% with room air (2) 24 hours without fever (≥38°C) (3) Breathing frequency < 24/min The percentage of patients with clinical cure at day 7 will be calculated |
Notes
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
nan |
Phase
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Phase 4 |
Arms
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "", "treatment_id": 279, "treatment_name": "Chloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1454, "treatment_name": "Azithromycin+chloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}] |